Dicranostigma Leptopodum (Maxim) Fedde (DL-F), which had been previously documented to suppress oxidative hemolysis of erythrocytes and enhance immune functions of murine peritoneal macrophages, was investigated for its effect on anti-tumor activity. Of alkaloids extracted from DLF, five have been identified with employment of chromatographic analysis. An antiproliferative role of these alkaloids was determined on SMMC-7721 Human Hepatoma Cells in an apoptosis-inducing manner, through MTT assaying, Trypan blue exclusion assaying and cytometric analysis of cell cycle distribution. To further examine their inhibitory effects on tumor progression, murine H22 cells were inoculated into Kunming mice to determine the role of these alkaloids of DLF in inhibiting tumor growth in the tumor-implanted mice. It was found that these alkaloids of DLF enhanced the tumor shrinkage effectively wherein its tumor inhibitory rate and immunohistochemistry staining of the tumor were determined and profiled, respectively.
INTRODUCTION
The medicinal use of natural products has a time-honored history along with the development of human civilization. Throughout human history, enormous range of natural products-compounds that are derived from natural sources such as plants, animals or micro-organismshave been discovered and put into medical use, the latest version of the Dictionary of Natural Products (DNP; http://dnp.chemnetbase.com) encompasses over 214,000 entries. These were identified as leads of drug through biological assay and became candidates for drug development. More than 60% of the marketed drugs derived from natural sources [1] . Owing to the diverse biological activities and medicinal potentials, the importance of natural products for medicine and health has been reportedly enormous with examining the experience and knowledge accumulated of use of natural products [2] . In light of their matchless resource and biologicallysynergic activities in vivo, they continue to contribute to the expansion of lead drugs and provide insights for synthesis of their non-natural analogues. Increasingly, Traditional Chinese medicine (TCM) is receiving recognition from modern western medicine and 908 components from Tradition Chinese Medicine Database were found structurally similar to those deposited in the Comprehensive Medicinal Chemistry database of which 327 agents were further identified as common members of both databases [3] . Although emphasis on high-throughput screening of synthetic libraries has in part declined drug discovery research into natural products during last two decades, the potential for new discoveries of activities of natural products in the long term is promising, given that the number of new natural product-derived drugs could go to zero [4] . Despite huge conceptual difference between Traditional Chinese Medicine (TCM) and Modern Western Medications, the preconception-TCM can't get them clinically approved -may be bridgeable with increased knowledge of molecular mechanisms of TCM-derived drugs [5] . By comparing 669 anti-tumor, anti-cancer or anti-neoplastic agents identified from Comprehensive Medicinal Chemistry database (CMC, containing 8659 clinically used Western drugs) to Traditional Chinese Medicine Database (TCMD, containing 10458 components), 26 pairs were found identical in structure and 20 were validated to be originally isolated from herbs [6] . With rationale borrowed from afore-mentioned discov-eries and previous findings that Dicranostigma leptopodum (maxim.) fedde (DLF) possessed physiological relevance of antipyretic and analgesic, detumescence, etc. (Dictionary of Traditional Chinese Medicine 1986), we further investigated its activities implicated in the induction of apoptosis of cancerous cells. The scientific name of DLF was for the first time coined and collectively classified by Harvard University Herbaria in 1987 (http://www.gbif.net/occurrences/86270582/). Enhanced effects of DLF on immune-suppression were determined in vivo [7] and its effect on suppressing oxidative hemolysis of erythrocytes was also validated [8] . Efforts made to separate and characterize the components of DLF have identified five crystals from DLF of which three were isocorydine, corydine and protopine [9] and five alkaloids isolated were dicranostigmine, isocorydine, corydine, protopine and sinoacutine [10] . In this study, we treated SMMC-7721Human Hepatoma Cells with extracted alkaloids of DLF, aiming to examine effect of alkaloids of DLF on inducing apoptosis of cancerous cells. Moreover, we treated H1-implanted Kunming Mice with alkaloids of DLF to have determined tumor growth-inhibiting effects of DLF.
EXPERIMENTAL MATERIALS AND METHOD

Materials
Extraction of Alakoids from DLF
The powdered material of roots, stems and leaves of DLF (12.5 g) was mixed with 75% alcohol (400 mL) for 1 h in a hermetic glass container and then disrupted continuously with an ultrasonic purge. The whole material was filtered in vacuum followed by a distillation process. Add alcohol to the mixture of filtrate to adjust its alcohol concentration to 85%. After 24 h, adjust the filtrate to pH 8.0 using NaOH and then filter and distill the filtrate until the alcohol is deprived. Adjust the filtrate to pH 7.0 using HCL [11] .
Determination of Alkaloids of DLF Extracts
20 mg/mL standard DLF extracts were diluted to concentrations of 0.1 mg/mL, 0.2 mg/mL, 0.3 mg/mL, 0.4 mg/mL, 0.5 mg/mL, 0.6 mg/mL and 0.7 mg/mL, respectively. The standard curve was made with these gradient concentrations and de-ionized water as control [12] . The separation of the alkaloids from DLF extracts was performed using Sephadex G-50 chromatograph analysis during which samples (50 ul) flowed through the Sephadex G-50 columns (0.1 mL) steadily at rate of 1 mL/min. The eluted proteins were determined at 254 nm wavelength by WD-9430D UV spectrophotometer.
Animals and Cells
Kunming mice were purchased from the Experimental Animal Center at Lanzhou University. The use and treatment of mice were in accordance with institutional guideline for Laboratory Animal Care. Muring H22 and SMMC-7721 Human Hepatoma cells were obtained from cell library of Institute of Cancer Biology and Drug Discovery, Lanzhou University. Cells were grown in RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (Lanzhou Minhai Biotechnology), 2 mM l-glutamine, 100 units/mL penicillin and 100 mg/ mL streptomycin and incubated at 37℃ in a humidified atmosphere of 5% CO 2 and 95% air.
Methods
MTT Assay
SMMC-7721 were plated in 96-well microtiter plates at a density of 4,000/well for culture and incubated in a humidified 5% CO 2 -95% air atmosphere at 37℃ for 24 h. Then cells were treated with different concentrations of alkaloids of DLF (0-24 mg/mL) and incubated for additional 24 h, 48 h, and 72 h respectively. Cell viability was determined by MTT assay [13] whereby 20 μL of 5 mg/mL MTT was added to each well and incubated for another 4 hours at 37℃. The supernatant was subsequently removed and 100 μL/well DMSO was added to dissolve the formazan crystal. After shaking plates for 1 min, the absorbance of each well was read at 570 nm wavelength with microplate reader (Bio-Rad). The viability of SMMC-7721 cells was calculated employing the formula below: Viability = (A 570 of treated cells/A 570 of untreated cells) × 100%
Trypan Blue Exclusion Assay
Trypan blue dye, which would be excluded by normal cells but could diffused into cells with disrupted membrane integrity, was employed to determine the number of the viable cells after treatment with alkaloids of DLF [14] . 24 hours after the SMMC-7721cells were treated with PMS-1077, measurements were conducted after trypan blue (Sigma) was incubated with SMMC-7721 cells for 5 min at room temperature. At least 500 cells were counted per sample. 
Morphological Analysis
To determine the morphological changes of SMMC-7721 cells upon treatment with alkaloids of DLF, SMMC-7721 cells which were treated with alkaloids of DLF for 24 h were observed under inverted dark field microscope (Nikon, Japan) and photographed afterwards.
Single Cell Gel Electrophoresis Assay
The single cell gel electrophoresis (SCGE) assay [15] commonly referred to as "comet assay" allowed the very sensitive detection of DNA breakage induced by genotoxic agents at single cell level. Thus, this method was adopted to determine the DNA damaging effects of alkaloids of DLF on SMMC-7721 cells. Treated with different concentrations of alkaloids of DLF for 24 h, SMMC-7721 cells were lysed by alkaline lysis solution (2.5 M NaCl, 100 mM EDTA•Na 2 , 10 mM Tris pH 10), 10% DMSO and 1% triton X-100 (Sigma) at 4℃ for 1 h. Another 20 min was allowed for the DNA to unwind in electrophoresis running buffer solution (300 mM NaOH, and 1 mM EDTA•Na 2 , pH 13). Electrophoresis was performed for 20 minutes at 50 V and 300 mA. After electrophoresis, the slides were gently removed and alkaline pH neutralized with 0.4 M Tris (pH 7.5). Then Ethidium bromide (75 mL of a 20 mg/mL solution, Sigma) was added to each slide and a cover glass was placed on the gel. DNA migration was analyzed on a fluorescence microscope (Olympus, Japan) (Filter G-2A) and photographed afterwards.
Flow Cytometric Analysis
SMMC-7721 cells that were treated with alkaloids of DLF for 24 h were washed twice with PBS and then fixed with 70% ethanol at -20℃ for about 12 h. Then cells were washed again twice with PBS and suspended with 1 mL 100 μg/mL RNase (Sigma) containing 0.1% Triton-100 and 50 μg/mL propidium iodide (Sigma). Cells were stained with DNA dye for 30 min and analyzed by flow cytometer (EPICS-XL, Beckman).
In Vivo Inhibition of Tumor Growth
Six-week old inbred female Kunming mice were inoculated with murine Hepatoma 2.0 × 107 mg/mL H22 cells [16] . From the second day after the implantation of H22 cells, 40 tumor-bearing mice were grouped randomly into five groups as the following: 1) Blank control, 2) Model control, 3) 5-Fu positive control, 4) High dose control, 5) Low dose control. 48h after tumor implantation, these mice were I.P. injected with a daily dose of 0.2 mL of 3.0 mg/mL, 0.2 mL 6.0 mg/mL, 0.2 mL, 2 mg/mL, 0.2 mL physiological saline (0.9%) and 0.2 mL physiological saline (0.9%) of alkaloids of DLF for High dose group, Low dose group, 5-Fu positive group, Blank group and Model group, respectively. Mice were executed within 24 h after the last dose of alkaloids of DLF and their tumor was obtained and analyzed. And Spleen and thymus indexes were examined. Tumor inhibitory rate (Ri) and organ index were expressed as the following formula, respectively [17] : 
Immunohistochemistry Analysis
The tumors of mice were excised and fixed in 4% paraformaldehyde for 24 h. Paraffin sections were prepared for immunohistochemical staining and hematoxylin and cosin (H & E) staining [18, 19] . Sections for immunohistochemical staining were deparaffinized and then hydrated by transferring them through the following solutions xylene bath twice for 5 min, 100% ethanol for 5 min twice, and then 90% ethanol, 80% ethanol, 70% ethanol, and PBS, for 3 min each. Subsequently, sections were placed in a microwave oven for 15 min at 100℃ in sodiumcitrate buffer (0.01 M, pH 5.7) to expose epitopes. After that, sections were incubated at 37℃ with PCNA antibody for about 1.5 h followed by the visualization using immunosystem kit (Santa Cruz, CA).
Statistical Analysis
All experimental data were expressed as mean ± SD, and statistical analysis was performed using Student's t-test to compare the results from the untreated group.
RESULTS AND DISCUSSION
Extraction and Determination of Alkaloids from DLF
The alkaloids extracted from DLF in roots, leaves and whole part were 5.31%, 5.91% and 5.57%, respectively. The average content of alkaloids in whole DLF part was 5.59%. Five main alkaloids were separated using chromatography and their contents were determined to be unevenly distributed, as indicated by the peaks of chromatographic profile (Figure 1) . 
Anti-Proliferative Effect of Alkaloids of DLF on SMMC-7721 Cells
Treated with assigned concentrations of alkaloids of DLF for indicated time, SMMC-7721 cells exhibited compromised cell viability. A concentration-dependent anti-proliferative effect of alkaloids of DLF on SMMC7721cells was determined by MTT assay and Trypan Blue Exclusion assay (Figure 2) .
Induction of Apoptosis of SMMC-7721 Cells by Alkaloids of DLF
Upon treatment with 8.5 mg/mL alkaloids of DLF for 24 h, SMMC-7721 cells exhibited the characteristic features of apoptosis including cell shrinkage, cell detachment and vesicle formation (Figure 3) . Flow cytometric analysis demonstrated that cell cycles were arrested ( Figure  4 ) and cell cycle distribution analysis manifested that cells were arrested predominately at G1 phase ( Figure  5 ).
Alkaloids of DLF-Induced DNA Damage of SMMC-7721 Cells
Upon treatment with various concentrations of alkaloids of DLF, SMMC-7721 cells exhibited characteristic fea- tures of DNA damage. Examination of DNA damage by Single cell gel electrophoresis revealed appreciable DNA damage in terms of its length of migrating tails ( Figure  6 ). It's also observed that the damage was concentrationdependent.
Inhibition of Tumor Growth by Alkaloids of DLF was Determined in Vivo
Murine Hepatoma H22 cells were inoculated to six-week old Kunming mice and, from 24 h after the inoculation, a daily dosage of alkaloids of DLF was I.P. injected into these tumor-bearing mice. After 12 days, mice were executed and their tumors, spleens and thymus were excised for analysis. Alkaloids of DLF exerted a role as potent as 5-Fu in enhancing tumor shrinkage. 5-Fu inhibited the tumor growth by 55.75% while 6.0 mg/mL alkaloids of DLF and 12.0 mg/mL alkaloids of DLF inhibited the growth of tumor by 42.50% and 51.00%, respectively ( Table 1) . By examining effects of alkaloids of DLF on the growth of spleen and thymus, it revealed that DLF exerted significant effect on inhibiting the aberrant progression thymus of tumor-bearing mice while the effects of alkaloids of DLF on the growth of spleen of tumor-bearing mice were not discernible ( Table 2 ).
Alkaloids of DLF-Mediated Inhibition of Tumor Progression Analyzed by HE Staining and Immunohistochemistry
Histological section of tumors excised from tumorbearing mice which were treated with 0.9% physiological saline, 5-FU, 6.0 mg/mL DLF and 12.0 mg/mL alkaloids of DLF were examined with employment of HE staining and Immunohistochemistry (Figure 7) . Both demonstrated that alkaloids of DLF exerted pronounced effects on inhibiting of the growth and progression of tumor.
Discussion
In response to the recognition that fewer side effects have been documented in phytotherapy and natural product-based therapy and therapeutic potential of natural products [5, 20, 21] , we further explored to study the antitumor activities of alkaloids of DLF. In this study, approx. 5.7% of alkaloids were extracted from the whole part of DLF and five alkaloids were identified using chromatographic analysis which was in consistence with the separation of alkaloids from DLF [10] . Anti-proliferative effect was determined for alkaloids of DLF on SMCC-7721 cells and IC 50 of alkaloids of DLF on SMCC-7721 cells was 8.5 mg/ml. Upon treatment with DLF, SMCC-7721 cells exhibited apoptotic features as a rule [11] . Flow cytometric analysis of cell cycle distribution upon treatment with alkaloids of DLF revealed that cells were arrested in the G1 phase (Figure 4 ) during which DNA damage was determined ( Figure 6 ). With in vitro anti-tumor activity of alkaloids of DLF validated, in vivo effect of anti-tumor of alkaloids of DLF was further explored. Tumor implantation was completed with inoculation of Muring H22 cells in Kunming mice. Inhibitory rates of 51% and 42% of tumor growth inhibition were determined for 12.0 mg/ml alkaloids of DLF and 6.0 mg/ml, respectively, through examining the tumor weight upon treating tumor-bearing mice with alkaloids of DLF. In addition, effects of alkaloids of DLF on inhibiting the progression tumor were determined by HE staining of histological section of tumors (Figure 7) . Taken together, an anti-tumor effect of alkaloids of DLF was determined by means of both in vitro and in vivo examinations. However, the elaborate molecular mechanism underlying its anti-tumor activity remains elusive for these five alkaloids. Since determining the biological properties of plants used in traditional medicine is helpful to drug screening, thus, further research is deserved to isolate the very compounds responsible for the observed biological activity of alkaloids of DLF.
CONCLUSIONS
With promising effects of alkaloids of DLF determined both in vitro and in vivo on anti-proliferating of SMCC-7721 cells and enhancing shrinkage of tumor, DLF deserves further characterization of its very components entailing its anti-tumor activities and mechanisms underlying its anti-tumor effect. Moreover, its anti-proliferating effect and anti-tumor activities remains to be extended to other cancerous cell lines and tumors as well. A comprehensive understanding of its activities on a spectrum of cancerous cells and tumors will shed light on its mechanistic elucidation of anti-tumor effects.
